Cargando…

Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries

BACKGROUND: WHO pneumonia guidelines recommend that children (aged 2-59 months) with chest indrawing pneumonia and without any “general danger sign” can be treated with oral amoxicillin without hospital admission. This recommendation was based on trial data from limited contexts whose generalisabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkes, Chris, Graham, Hamish, Walker, Patrick, Duke, Trevor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428503/
https://www.ncbi.nlm.nih.gov/pubmed/36040992
http://dx.doi.org/10.7189/jogh.12.10008
_version_ 1784779134258380800
author Wilkes, Chris
Graham, Hamish
Walker, Patrick
Duke, Trevor
author_facet Wilkes, Chris
Graham, Hamish
Walker, Patrick
Duke, Trevor
author_sort Wilkes, Chris
collection PubMed
description BACKGROUND: WHO pneumonia guidelines recommend that children (aged 2-59 months) with chest indrawing pneumonia and without any “general danger sign” can be treated with oral amoxicillin without hospital admission. This recommendation was based on trial data from limited contexts whose generalisability is unclear. This review aimed to identify which children with chest-indrawing pneumonia in low- and middle-income countries can be safely treated at home, and under what conditions is it safe to do so. METHODS: We searched MEDLINE, EMBASE, and PubMed for observational and interventional studies of home-based management of children (aged 28 days to four years) with chest-indrawing pneumonia in low- or middle-income countries. RESULTS: We included 14 studies, including seven randomised trials, from a variety of urban and rural contexts in 11 countries. Two community-based and two hospital-based trials in Pakistan and India found that home treatment of chest-indrawing pneumonia was associated with similar or superior treatment outcomes to hospital admission. Evidence from trials (n = 3) and observational (n = 6) studies in these and other countries confirms the acceptability and feasibility of home management of chest-indrawing pneumonia in low-risk cases, so long as safeguards are in place. Risk assessment includes clinical danger signs, oxygen saturation, and the presence of comorbidities such as undernutrition, anaemia, or HIV. Pulse oximetry is a critical risk-assessment tool that is currently not widely available and can identify severely ill patients with hypoxaemia otherwise possibly missed by clinical assessment alone. Additional safeguards include caregiver understanding and ability to return for review. CONCLUSIONS: Home treatment of chest-indrawing pneumonia can be safe but should only be recommended for children confirmed to be low-risk and in contexts where appropriate care and safety measures are in place.
format Online
Article
Text
id pubmed-9428503
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Global Health
record_format MEDLINE/PubMed
spelling pubmed-94285032022-09-07 Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries Wilkes, Chris Graham, Hamish Walker, Patrick Duke, Trevor J Glob Health Research Theme 6: Pneumonia and Diarrhoea in Children BACKGROUND: WHO pneumonia guidelines recommend that children (aged 2-59 months) with chest indrawing pneumonia and without any “general danger sign” can be treated with oral amoxicillin without hospital admission. This recommendation was based on trial data from limited contexts whose generalisability is unclear. This review aimed to identify which children with chest-indrawing pneumonia in low- and middle-income countries can be safely treated at home, and under what conditions is it safe to do so. METHODS: We searched MEDLINE, EMBASE, and PubMed for observational and interventional studies of home-based management of children (aged 28 days to four years) with chest-indrawing pneumonia in low- or middle-income countries. RESULTS: We included 14 studies, including seven randomised trials, from a variety of urban and rural contexts in 11 countries. Two community-based and two hospital-based trials in Pakistan and India found that home treatment of chest-indrawing pneumonia was associated with similar or superior treatment outcomes to hospital admission. Evidence from trials (n = 3) and observational (n = 6) studies in these and other countries confirms the acceptability and feasibility of home management of chest-indrawing pneumonia in low-risk cases, so long as safeguards are in place. Risk assessment includes clinical danger signs, oxygen saturation, and the presence of comorbidities such as undernutrition, anaemia, or HIV. Pulse oximetry is a critical risk-assessment tool that is currently not widely available and can identify severely ill patients with hypoxaemia otherwise possibly missed by clinical assessment alone. Additional safeguards include caregiver understanding and ability to return for review. CONCLUSIONS: Home treatment of chest-indrawing pneumonia can be safe but should only be recommended for children confirmed to be low-risk and in contexts where appropriate care and safety measures are in place. International Society of Global Health 2022-08-31 /pmc/articles/PMC9428503/ /pubmed/36040992 http://dx.doi.org/10.7189/jogh.12.10008 Text en Copyright © 2022 by the Journal of Global Health. All rights reserved. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Theme 6: Pneumonia and Diarrhoea in Children
Wilkes, Chris
Graham, Hamish
Walker, Patrick
Duke, Trevor
Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title_full Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title_fullStr Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title_full_unstemmed Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title_short Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries
title_sort which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? a systematic review of evidence from low- and middle-income countries
topic Research Theme 6: Pneumonia and Diarrhoea in Children
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428503/
https://www.ncbi.nlm.nih.gov/pubmed/36040992
http://dx.doi.org/10.7189/jogh.12.10008
work_keys_str_mv AT wilkeschris whichchildrenwithchestindrawingpneumoniacanbesafelytreatedathomeandunderwhatconditionsisitsafetodosoasystematicreviewofevidencefromlowandmiddleincomecountries
AT grahamhamish whichchildrenwithchestindrawingpneumoniacanbesafelytreatedathomeandunderwhatconditionsisitsafetodosoasystematicreviewofevidencefromlowandmiddleincomecountries
AT walkerpatrick whichchildrenwithchestindrawingpneumoniacanbesafelytreatedathomeandunderwhatconditionsisitsafetodosoasystematicreviewofevidencefromlowandmiddleincomecountries
AT duketrevor whichchildrenwithchestindrawingpneumoniacanbesafelytreatedathomeandunderwhatconditionsisitsafetodosoasystematicreviewofevidencefromlowandmiddleincomecountries
AT whichchildrenwithchestindrawingpneumoniacanbesafelytreatedathomeandunderwhatconditionsisitsafetodosoasystematicreviewofevidencefromlowandmiddleincomecountries